Search

for
Search:

GlossaryLeuprolide (Leuprorelin)

medication that reduces hormone levels to treat certain conditions

Leuprolide, also known as Lupron, is a medication that acts as a gonadotropin-releasing hormone (GnRH) agonist. It is commonly used to treat hormone-sensitive conditions such as prostate cancer, endometriosis, and uterine fibroids by reducing the production of certain hormones like testosterone and estrogen. This reduction can help manage symptoms and slow the progression of these conditions.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 49 results

research Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin

36 citations , May 2011 in “The Journal of Clinical Endocrinology & Metabolism”

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

research Hypothalamic Hamartoma with Precocious Puberty and Gelastic Seizures in a Boy: Case Report

October 2013 in “International Journal of Pediatric Endocrinology/International journal of pediatric endocrinology”

A boy with early puberty and laughing seizures was treated, stopping seizures and slowing puberty.

Presentation of a Meningioma in a Transwoman After Nine Years of Cyproterone Acetate and Estradiol Intake: Case Report and Literature Review

research Presentation of a Meningioma in a Transwoman After Nine Years of Cyproterone Acetate and Estradiol Intake: Case Report and Literature Review

34 citations , November 2017 in “Gynecological Endocrinology”

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

research News And Notes

May 2008 in “Trends in Urology Gynaecology & Sexual Health”

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Androgenic Effects on Ventricular Repolarization: A Translational Study from Pharmacovigilance Databases to iPSC-Cardiomyocytes

research Androgenic Effects on Ventricular Repolarization: A Translational Study from Pharmacovigilance Databases to iPSC-Cardiomyocytes

October 2019 in “European heart journal”

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

View more "leuprorelin" in research →

Community Join

3 / 3 results

community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

in Research/Science 124 upvotes 2 years ago

The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

community 21 months on topical minoxidil and full HRT

in Transgender 214 upvotes 1 year ago

The conversation is about a transgender individual's experience with hair regrowth using topical minoxidil and hormone replacement therapy (HRT), expressing concern about the slow growth and thin appearance of their hair. Some responses encourage patience and highlight the variability of results, while others discuss the role of HRT and its effects.

community 10 months treating MPB - I am happy with these results

in Progress Pictures 8 upvotes 8 months ago

A 26-year-old man shared his positive results after 10 months of treating male pattern baldness using a regimen that includes Estradiol Enanthate, DHPA, Bicalutamide, Dutasteride, oral and topical Minoxidil, and a dermaroller. He experienced mild gynecomastia and reduced body hair as side effects but was satisfied with the outcome.